OrphanPacific Front

President's Message

Corporate Philosophy

Activities

Who we are

Japan Market Entry

News Release

Announcement Regarding the Designation of Glycerol Phenylbutyrate as an Orphan Drug

Announcement of Application for Approval of Glycerol Phenylbutyrate for the Treatment of Urea Cycle Disorder

Announcement of Marketing Authorization Transfer for Rabipur Intramuscular Injection

Updated Who we are

Announcement for Initiation of Phase III Trial of Glycerol Phenylbutyrate in Urea Cycle Disorders in Japan

All News Release

We associate with the activities of Rare Disease Day JAPAN and support activities.